SERA PROGNOSTICS, INC. - Class A Common Stock $0.0001 par value per share (SERA)

CUSIP: 81749D107

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
-2,887,131
SEC-reported price per share
$1.82
Number of holders
46
Value change
-$5,869,162
Number of buys
11
Number of sells
21
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
38,190,361

Security key

81749D107

Report period

Q2 2026

Institutions

46

Top holders

10

Ownership snapshot

Top reported holders of SERA - SERA PROGNOSTICS, INC. - Class A Common Stock $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
5/15
Latest evidence
30 Jun 2026
13D/G 3/4/5 13F Lead comparable stake: 16% 10 rows are not safely comparable across share classes. 13D/G row: BAKER BROS. ADVISORS LP Showing 1-6 of 15 holder rows.

Quick read

BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 16%.

5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership Top 5
BAKER BROS. ADVISORS LP 16%
Whetstone Capital Advisors, LLC 8.6%
Chione Ltd 7.6%
Aberdeen Group plc 7.2%
Vivo Capital IX, LLC 4.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BAKER BROS. ADVISORS LP
13D/G 3/4/5 13F
10%+ Owner · Company
16%
Reported 13D/G · 12 Feb 2025
$18,418,870
5,498,170 shares
$0 12 Feb 2025
Whetstone Capital Advisors, LLC
13D/G 13F
Company
8.6%
Reported 13D/G · 31 Mar 2026
$7,341,294
3,306,889 shares
-$339,269 31 Mar 2026
Chione Ltd
13D/G
7.6%
Reported 13D/G · 11 Feb 2025
$8,727,926
2,605,351 shares
$0 11 Feb 2025
Aberdeen Group plc
13D/G 13F
Company
7.2%
Reported 13D/G · 30 Jun 2026
$5,507,050
2,753,525 shares
+$1,052,316 30 Jun 2026
Vivo Capital IX, LLC
13D/G
4.5%
Reported 13D/G · 31 Mar 2025
$5,528,974
1,650,440 shares
$0 31 Mar 2025
Blue Ox Healthcare Partners, LLC
3/4/5
10%+ Owner
—
denominator unverified
$1,339,791
256,665 shares
— 18 Jul 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
46
Shares
17,056,654
Rows available
46
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q4 2025 Across Filers

Q4 2025 holders
56
Q2 2026 holders
46
Holder diff
-10
Investor Q4 2025 Shares Q2 2026 Shares Share Diff Share Chg % Q4 2025 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .